MSCs significantly reduced the levels of inflammatory cytokines (IL-6, IFN-γ, and TNF-α) in BALF to promote lung injury repair, which is consistent with the previous finding that blocking TNF-α attenuated the severity of LPS-induced ALI 33. The gene discussed is TNF; the disease is acute respiratory distress syndrome.